FR2336130A1 - Composes utilisables dans le traitement des infections bacteriennes - Google Patents

Composes utilisables dans le traitement des infections bacteriennes

Info

Publication number
FR2336130A1
FR2336130A1 FR7609025A FR7609025A FR2336130A1 FR 2336130 A1 FR2336130 A1 FR 2336130A1 FR 7609025 A FR7609025 A FR 7609025A FR 7609025 A FR7609025 A FR 7609025A FR 2336130 A1 FR2336130 A1 FR 2336130A1
Authority
FR
France
Prior art keywords
clavulanic
urinary tract
infections
respiratory
illness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7609025A
Other languages
English (en)
Other versions
FR2336130B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB15209/75A external-priority patent/GB1545467A/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of FR2336130A1 publication Critical patent/FR2336130A1/fr
Application granted granted Critical
Publication of FR2336130B1 publication Critical patent/FR2336130B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/02—Preparation
    • C07D503/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
FR7609025A 1975-04-14 1976-03-29 Composes utilisables dans le traitement des infections bacteriennes Granted FR2336130A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB15209/75A GB1545467A (en) 1975-04-14 1975-04-14 Deoxyclavulanic acid and deoxyisoclavulanic acid and derivatives thereof
GB3967175 1975-09-27

Publications (2)

Publication Number Publication Date
FR2336130A1 true FR2336130A1 (fr) 1977-07-22
FR2336130B1 FR2336130B1 (fr) 1979-06-22

Family

ID=26251136

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7609025A Granted FR2336130A1 (fr) 1975-04-14 1976-03-29 Composes utilisables dans le traitement des infections bacteriennes

Country Status (22)

Country Link
JP (1) JPS51127093A (fr)
AR (1) AR208773A1 (fr)
AT (1) AT342199B (fr)
AU (1) AU497577B2 (fr)
CA (1) CA1074802A (fr)
CH (1) CH602742A5 (fr)
DE (1) DE2616088A1 (fr)
DK (1) DK144066C (fr)
ES (1) ES446468A1 (fr)
FI (1) FI760946A (fr)
FR (1) FR2336130A1 (fr)
GR (1) GR58256B (fr)
HU (1) HU175444B (fr)
IE (1) IE42666B1 (fr)
IL (1) IL49279A (fr)
LU (1) LU74749A1 (fr)
MX (1) MX3453E (fr)
NL (1) NL7603840A (fr)
NO (1) NO761241L (fr)
PT (1) PT64897B (fr)
SE (1) SE427037B (fr)
YU (1) YU69476A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364216A1 (fr) * 1976-09-09 1978-04-07 Glaxo Lab Ltd Derives de la clavuline et leur procede de preparation
WO1991015208A1 (fr) * 1990-03-30 1991-10-17 Beecham Group Plc Traitement veterinaire

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT363181B (de) * 1976-10-25 1981-07-10 Glaxo Lab Ltd Verfahren zur herstellung von neuen clavulansaeurederivaten

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364216A1 (fr) * 1976-09-09 1978-04-07 Glaxo Lab Ltd Derives de la clavuline et leur procede de preparation
WO1991015208A1 (fr) * 1990-03-30 1991-10-17 Beecham Group Plc Traitement veterinaire

Also Published As

Publication number Publication date
ES446468A1 (es) 1977-11-01
GR58256B (en) 1977-09-15
HU175444B (hu) 1980-08-28
DK156576A (da) 1976-10-15
YU69476A (en) 1982-05-31
JPS51127093A (en) 1976-11-05
MX3453E (es) 1980-12-03
ATA215576A (de) 1977-07-15
NO761241L (fr) 1976-10-15
IE42666B1 (en) 1980-09-24
FI760946A (fr) 1976-10-15
SE7604287L (sv) 1976-10-15
CH602742A5 (fr) 1978-07-31
PT64897B (en) 1977-08-18
AR208773A1 (es) 1977-02-28
AU1302076A (en) 1977-10-20
IL49279A0 (en) 1976-06-30
DE2616088A1 (de) 1976-10-28
DK144066C (da) 1982-05-10
AU497577B2 (en) 1978-12-21
LU74749A1 (fr) 1976-11-11
DK144066B (da) 1981-11-30
IE42666L (en) 1976-10-14
PT64897A (en) 1976-04-01
SE427037B (sv) 1983-02-28
CA1074802A (fr) 1980-04-01
AT342199B (de) 1978-03-28
NL7603840A (nl) 1976-10-18
IL49279A (en) 1979-05-31
FR2336130B1 (fr) 1979-06-22

Similar Documents

Publication Publication Date Title
Esposito et al. Topical and oral treatment of chronic otitis media with ciprofloxacin: a preliminary study
BR9406979A (pt) Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal
IT8267464A0 (it) Composti cefalosporinici particolarmente per la cura delle affezioni da batteri gram positivi e gramnegativi composizioni farmaceutiche che li contengono e procedimento per la loro fabbricazione
US6017912A (en) Topical fluoroquinolone antibiotics in an alcohol and acetone vehicle
RU94008616A (ru) 2-тиозамещенные карбапенемы, промежуточные соединения для получения, способы получения, фармацевтическая композиция, способ лечения бактериальных инфекций
ES8500931A1 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
FR2336130A1 (fr) Composes utilisables dans le traitement des infections bacteriennes
FR2342292A1 (fr) Antibiotiques, inhibiteurs de b-lactamases, clavulamiques et leur procede de preparation
US3218335A (en) Antibiotic compounds
EP0009636A3 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivative, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds in the treatment and prophylaxis of diseases and for promoting growth of certain animals, and their manufacture
ES475660A1 (es) Un procedimiento para la preparacion de un tiol acido y sus sales y esteres
GB1392241A (en) Antibacterial agents and a process for the preparation thereof
FR2335208A1 (fr) Nouveaux derives de la spermine a activite bacteriostatique, procede pour leur fabrication et compose pharmaceutique les contenant
ES8101576A1 (es) Un procedimiento para la preparacion de derivados del acido monico
IT1036078B (it) Composizione antibatterica per anima i
Henning et al. Cefadroxil single-dose long and short therapy versus amoxicillin in female urinary tract infections
SE8404556D0 (sv) Farmaceutisk komposition
ES458790A1 (es) Un procedimiento para la produccion de acido 6-(d-2(3-hi- droxipiridazin-4-carbonamido)-2-(p-hidroxifenil) acetamido) penicilanico.
HU171232B (hu) Sposob poluchenija proizvodnykh 7-kvadratnaja skobka-skobka-2-aminometil-fenil-skobka zakrita-acetamido-kvadratnaja skobka zakryta-3-tiadiazolil-tiometil-cef-3-em-4-karbonovojj kisloty
FR2372630A1 (fr) Agents antibacteriens du type de la cephalosporine
Kaplan et al. Clinical evaluation of furadantin, a new urinary antiseptic
Colley et al. Penicillin G—treatment of urinary infection in paraplegia
Barclay et al. Long-term, low-dose treatment with pivmecillinam alone and in combination with pivampicillin in patients prone to recurrent bacteriuria
Lingard The Treatment of Urinary Tract Infections
FR2007387A1 (en) P-hydroxyphenylhydrazones antibacterial

Legal Events

Date Code Title Description
ST Notification of lapse